Jamaican pharmaceutical distributor RA Williams Distributors Limited has unveiled a strategic expansion of its ophthalmic product line, positioning the company’s eyecare segment as a key new driver of long-term revenue growth. The move builds on a 14-year distribution partnership with Aristopharma Limited, and adds three new dry eye and ocular surface treatments — Drylief, Neotear, and Hypomer Gel — to the company’s existing portfolio. The expansion is designed to widen local patient access to advanced specialized ocular care, while cementing RA Williams’ footprint in the high-value, prescriber-led eyecare market.
In an interview with Jamaica Observer and Business Observer this week, RA Williams CEO Audley Reid emphasized that the latest portfolio addition aligns with the firm’s core mission: to deliver quality pharmaceutical solutions that connect global medical innovation to Jamaica’s local healthcare needs. “Fourteen years ago, we entered the eyecare market with Aristobet-N, and our mission remains the same,” Reid explained. “As a pharmacist-led organisation, this expansion into ocular health is not just a product launch; it is a strategic move to capture high-value market share in a segment with strong patient retention and consistent demand.”
The new range of Aristopharma ocular lubricants directly addresses fast-rising local demand for dry eye and ocular surface therapies, a trend fueled in large part by soaring daily screen time and the growing prevalence of computer vision syndrome. By offering tiered treatment options that cater to everything from mild eye irritation to chronic dry eye conditions, the new products give local clinicians greater flexibility to tailor care to individual patient needs.
Against a backdrop of recent industry headwinds, including hurricane-related supply disruptions and broad macroeconomic challenges that weighed on the firm’s performance in prior quarters, Reid noted that the timing of the ophthalmic expansion is well-calendar to deliver steady incremental revenue growth over the next 18 to 24 months, supported by the category’s consistent, non-cyclical demand. “By diversifying our portfolio into the ‘wellness and lifestyle’ space, we aim to capture a broader share of consumer spending while insulating revenue against fluctuations in any single sector,” he said.
The eyecare expansion is the latest step in RA Williams’ broader push to diversify beyond traditional pharmaceuticals into fast-growing wellness and preventive care segments. The firm already notched a notable financial turnaround recently: for the first quarter ending January 31, 2026, RA Williams reported a net profit of JMD $33.5 million, double the profit recorded in the same period a year prior, on total revenues of JMD $541.9 million, reversing losses reported in the previous quarter.
Earlier this year, the company entered a new partnership with Jamaican dermatologist Dr Romario Thomas to distribute his clinical-grade skincare brand Absolut Skin, and has ramped up efforts to place both new and existing wellness products in the country’s largest retail chains. Reid confirmed that Absolut Skin is in the final onboarding stage for MegaMart, one of Jamaica’s leading big-box retail chains, with products set to hit shelves by the end of the week. “This move complements our existing presence in the pharmacy network as we push to bring clinical-grade skincare to a wider supermarket demographic,” Reid said.
Established wellness lines from RA Williams have already seen growing traction across alternative retail channels. The brand’s popular Sir Henry Turmeric Immunity Shots have gained a loyal consumer base across warehouse clubs, convenience stores, and gas station networks across the island. “Our retail push has been allowing us to tap into the growing ‘on-the-go’ wellness trend across multiple networks,” Reid added.
Moving forward, RA Williams will continue to pursue a dual-track growth strategy that balances its core traditional pharmaceutical business with its expanding wellness portfolio. Management will prioritize filling unmet gaps in chronic disease care, while also scaling promising local Jamaican brands with national distribution potential. Reid highlighted that supporting local innovation is a core pillar of the firm’s long-term growth plan.
“Lines like Sir Henry and Absolut Skin are world-class Jamaican brands, and we see ourselves as the bridge bringing them to a wider national audience,” Reid said. “Whether it is a life-saving medication in a pharmacy or a wellness shot in a supermarket, we are ensuring that R A Williams is present wherever the Jamaican consumer prioritises their health. By combining specialised medical treatments with high-velocity wellness products, we are building a diversified portfolio that is resilient, accessible and uniquely Jamaican.”